Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
The phase 2 ketamine trial for tinnitus was completed but has not yet reported its main results.
Yes, Hadlima (adalimumab) is FDA-approved to treat moderately to severely active polyarticular juvenile idiopathic arthritis in patients aged 2 years and older.
Yes, machine learning models using registry data can predict inactive disease in juvenile idiopathic arthritis with about 70-76% accuracy, but they are not yet ready for routine…
Extracellular vesicles (EVs) act as promising biomarkers for neurological disorders like Alzheimer's and Parkinson's, offering a less invasive way to detect disease signals in…
Yes, pucotenlimab has caused severe adverse reactions, including a fatal case of neuromyelitis optica spectrum disorder (NMOSD) in a patient with cancer.
Animal models for NMOSD include AQP4-peptide immunized mice, passive transfer models, and T-cell-based models, each capturing different aspects of pathogenesis.
Yes, DATSCAN imaging helps diagnose dementia with Lewy bodies by showing reduced dopamine transport in the brain, which supports the diagnosis when other symptoms are unclear.
People with iRBD biomarkers show worse cognitive performance than healthy controls, with higher rates of mild cognitive impairment and neuropsychiatric symptoms.
Yes, machine learning with cfDNA can detect liver cancer at various stages, with sensitivities ranging from 44% for stage I to 99% for stage III and high specificity.
Research shows liver cancer detection using liquid biopsies has high accuracy similar to lung, breast, and kidney cancers, while survival rates for liver cancer have improved…
UK Biobank data shows metabolic syndrome, sedentary lifestyles, smoking, and alcohol use increase chronic pancreatitis risk, while a Mediterranean diet lowers it.
Activating the aryl hydrocarbon receptor can cause liver damage or protect it depending on the specific signals and context, acting as a double-edged sword in liver health.
Yes, mitochondrial dysfunction is a key driver of liver injury, contributing to cell death and disease progression in conditions like fatty liver and alcohol-associated liver…
Yes, having metabolic syndrome significantly increases your risk of developing chronic pancreatitis, with studies showing the risk more than doubles.
A 2025 meta-analysis found no significant difference in mortality between anterior and posterior circulation aneurysm locations in subarachnoid hemorrhage patients.
Research shows that aneurysm location does not significantly change mortality or functional recovery outcomes in subarachnoid hemorrhage, though specific ECG changes can vary by…
Yes, children with genetic focal epilepsy often have specific diagnoses based on the exact gene mutation found, such as SCN1A or PCDH19, which also predict early onset and…
The Hong Kong consensus recommends immunotherapy-based combinations for first-line metastatic renal cell carcinoma, active surveillance for select patients, and specific…
Yes, certain genetic mutations are linked to earlier seizure onset in children with focal epilepsy, with some variants associated with onset in the first months of life.
Recent reviews suggest quercetin has anti-inflammatory and antioxidant properties that could help with gout, but there is currently no strong clinical proof it works for gouty…
Yes, people with Parkinson disease tend to have a higher burden of cerebral small vessel disease than healthy controls, which may worsen motor and cognitive symptoms.
In gouty arthritis, macrophages shift their energy use from oxidative phosphorylation to glycolysis and change from pro-inflammatory to anti-inflammatory states as the attack…
Yes, genetic markers for diabetes are linked to cerebral small vessel disease risk, but they are not a standalone predictor; other factors like blood pressure also matter.
Current gout models fail because they do not fully capture the complex metabolic changes in macrophages or the chronic, multi-factorial nature of human disease.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.